Cough in Lower Airway Infections

Cough: Causes, Mechanisms and Therapy

Volumn , Issue , 2008, Pages 81-96

  Pek, Wee Yang ^a   Boushey, Homer A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Acute tracheobronchitis; Airway infections; Epidemiology; Influenza epidemics; Pneumonia

Indexed keywords

EID: 84948800209     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470755846.ch9     Document Type: Chapter

References (113)

1. Schappert SM. Ambulatory care visits of physician offices, hospital outpatient departments, and emergency departments: United States, 1995. Vital Health Stat 13 1997; 129: 1-38.
2. Ayres JG. Seasonal pattern of acute bronchitis in general practice in the United Kingdom 1976-83. Thorax 1986; 41 (2): 106-10.
3. Oeffinger KC, Snell LM, Foster BM, Panico KG, Archer RK. Diagnosis of acute bronchitis in adults: a national survey of family physicians. J Fam Pract 1997; 45 (5):402-9.
4. Evan AS. Clinical syndromes in adults caused by respiratory infection. Med Clin North Am 1967; 51: 803-18.
5. Shay DK, Holman RC, Newman RD, Liu LL, Stout JW, Anderson LJ. Bronchiolitis-associated hospitalizations among US children, 1980-96. JAMA 1999; 282 (15):1440-6.
6. Henderson FW, Clyde WA Jr, Collier AM, Denny FW, Senior RJ, Sheaffer CI et al. The etiologic and epidemiologic spectrum of bronchiolitis in pediatric practice. J Pediatr 1979; 95 (2): 183-90.
7. Welliver RC, Wong DT, Sun M, McCarthy N. Parainfluenza virus bronchiolitis. Epidemiology and pathogenesis. Am J Dis Child 1986; 140 (1): 34-40.
8. Denny FW, Murphy TF, Clyde WA Jr, Collier AM, Henderson FW. Croup: an 11-year study in a pediatric practice. Pediatrics 1983; 71 (6): 871-6.
9. Hall CB. Respiratory syncytial virus and parainfluenza virus. N Engl J Med 2001; 344 (25): 1917-28.
10. Sendi K, Crysdale WS, Yoo J. Tracheitis: outcome of 1,700 cases presenting to the emergency department during two years. J Otolaryngol 1992; 21 (1): 20-4.
11. Nicholson KG, Kent J, Hammersley V, Cancio E. Acute viral infections of upper respiratory tract in elderly people living in the community: comparative, prospective, population based study of disease burden. Br Med J 1997; 315 (7115): 1060-4.
12. Falsey AR, McCann RM, Hall WJ, Tanner MA, Criddle MM, Formica MA et al. Acute respiratory tract infection in daycare centers for older persons. J Am Geriatr Soc 1995; 43 (1): 30-6.
13. Pitkaranta A, Virolainen A, Jero J, Arruda E, Hayden FG. Detection of rhinovirus, respiratory syncytial virus, and coronavirus infections in acute otitis media by reverse transcriptase polymerase chain reaction. Pediatrics 1998; 102: 291-5.
14. Nicholson KG, Kent J, Hammersley V, Cancio E. Risk factors for lower respiratory complications of rhinovirus infections in elderly people living in the community:prospective cohort study. Br Med J 1996; 313: 1119-23.
15. Van Hartesveldt FR. The 1918-1919 Pandemic of Influenza: the Urban Impact in the Western World. Lewiston, NY: E. Mellen Press, 1992.
16. Crosby AW. America's Forgotten Pandemic: the Influenza of 1918. Cambridge, UK: Cambridge University Press, 1989.
17. Denny FW Jr. The clinical impact of human respiratory virus infections. Am J Respir Crit Care Med 1995; 152:S4-12.
18. Boldy DA, Skidmore SJ, Ayres JG. Acute bronchitis in the community: clinical features, infective factors, changes in pulmonary function and bronchial reactivity to histamine. Respir Med 1990; 84 (5): 377-85.
19. Monto AS. Viral respiratory infections in the community:epidemiology, agents and interventions. Am J Med 1995; 99: 24S-27S.
20. Monto AS, Sullivan KM. Acute respiratory illness in the community. Frequency of illness and the agents involved. Epidemiol Infect 1993; 110 (1): 145-60.
21. Gern JE, Galagan DM, Jarjour NN, Dick EC, Busse WW. Detection of rhinovirus RNA in lower airway cells during experimentally induced infection. Am J Respir Crit Care Med 1997; 155 (3): 1159-61.
22. Monto AS, Fendrick AM, Sarnes MW. Respiratory illness caused by picornavirus infection: a review of clinical outcomes. Clin Ther 2001; 23 (10): 1615-27.
23. Johnston SL, Pattemore PK, Sanderson G, Smith S, Lampe F, Josephs L et al. Community study of role of viral infections in exacerbations of asthma in 9-11 year old children. Br Med J 1995; 310: 1225-9.
24. Nicholson KG, Kent J, Ireland DC. Respiratory viruses and exacerbations of asthma in adults. Br Med J 1993; 307: 982-6.
25. Seemungal TA, Harper-Owen R, Bhowmik A, Jeffries DJ, Wedzicha JA. Detection of rhinovirus in induced sputum at exacerbation of chronic obstructive pulmonary disease. Eur Respir J 2000; 16 (4): 677-83.
26. Wedzicha JA. Exacerbations: etiology and pathophysiologic mechanisms. Chest 2002; 121 (5 Suppl.):136S-41S.
27. Greenberg SB, Allen M, Wilson J, Atmar RL. Respiratory viral infections in adults with and without chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2000; 162 (1): 167-73.
28. Smyth AR, Smyth RL, Tong CY, Hart CA, Heaf DP. Effect of respiratory virus infections including rhinovirus on clinical status in cystic fibrosis. Arch Dis Child 1995; 73 (2): 117-20.
29. Mink CM, Cherry JD, Christenson P, Lewis K, Pineda E, Shlian D et al. A search for Bordetella pertussis infection in university students. Clin Infect Dis 1992; 14 (2):464-71.
30. Nennig ME, Shinefield HR, Edwards KM, Black SB, Fireman BH. Prevalence and incidence of adult pertussis in an urban population. JAMA 1996; 275 (21): 1672-4.
31. Grayston JT, Kuo CC, Wang SP, Altman J. A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. N Engl J Med 1986; 315 (3):161-8.
32. Wright SW, Edwards KM, Decker MD, Grayston JT, Wang S. Prevalence of positive serology for acute Chlamydia pneumoniae infection in emergency department patients with persistent cough. Acad Emerg Med 1997; 4 (3): 179-83.
33. Gonzales R, Malone DC, Maselli JH, Sande MA. Excessive antibiotic use for acute respiratory infections in the United States. Clin Infect Dis 2001; 33 (6): 757-62.
34. Gonzales R, Steiner JF, Sande MA. Antibiotic prescribing for adults with colds, upper respiratory tract infections, and bronchitis by ambulatory care physicians. JAMA 1997; 278 (11): 901-4.
35. Metlay JP, Stafford RS, Singer DE. National trends in the use of antibiotics by primary care physicians for adult patients with cough. Arch Intern Med 1998; 158 (16):1813-18.
36. Niederman MS, Mandell LA, Anzueto A, Bass JB, Broughton WA, Campbell GD et al. Guidelines for the management of adults with community-acquired pneumonia. Diagnosis, assessment of severity, antimicrobial therapy, and prevention. Am J Respir Crit Care Med 2001; 163 (7): 1730-54.
37. Bartlett JG, Breiman RF, Mandell LA, File TM Jr. Community-acquired pneumonia in adults: guidelines for management. The Infectious Diseases Society of America. Clin Infect Dis 1998; 26 (4): 811-38.
38. Macfarlane JT, Finch RG, Ward MJ, Macrae AD. Hospital study of adult community-acquired pneumonia. Lancet 1982; 2: 255-8.
39. Ostergaard L, Andersen PL. Etiology of communityacquired pneumonia. Evaluation by transtracheal aspiration, blood culture, or serology. Chest 1993; 104 (5):1400-7.
40. Bartlett JG, Mundy LM. Community-acquired pneumonia. N Engl J Med 1995; 333 (24): 1618-24.
41. Ruiz M, Ewig S, Marcos MA, Martinez JA, Arancibia F, Mensa J et al. Etiology of community-acquired pneumonia:impact of age, comorbidity, and severity. Am J Respir Crit Care Med 1999; 160 (2): 397-405.
42. Ruiz M, Ewig S, Torres A, Arancibia F, Marco F, Mensa J et al. Severe community-acquired pneumonia. Risk factors and follow-up epidemiology. Am J Respir Crit Care Med 1999; 160 (3): 923-9.
43. Gwaltney JM Jr. Rhinovirus infection of the normal human airway. Am J Respir Crit Care Med 1995; 152:S36-9.
44. Halperin SA, Eggleston PA, Hendley JO, Suratt PM, Groschel DH, Gwaltney JM Jr. Pathogenesis of lower respiratory tract symptoms in experimental rhinovirus infection. Am Rev Respir Dis 1983; 128 (5): 806-10.
45. Folkerts G, Busse WW, Nijkamp FP, Sorkness R, Gern JE. Virus-induced airway hyperresponsiveness and asthma. Am J Respir Crit Care Med 1998; 157: 1708-20.
46. Loosli CG, Stinson SF, Ryan DP, Hertweck MS, Hardy JD, Serebrin R. The destruction of type 2 pneumocytes by airborne influenza PR8-A virus; its effect on surfactant and lecithin content of the pneumonic lesions of mice. Chest 1975; 67 (2 Suppl.): 7S-14S.
47. Aherne W, Bird T, Court SD, Gardner PS, McQuillin J. Pathological changes in virus infections of the lower respiratory tract in children. J Clin Pathol 1970; 23 (1):7-18.
48. Borson DB, Brokaw JJ, Sekizawa K, McDonald DM, Nadel JA. Neutral endopeptidase and neurogenic inflammation in rats with respiratory infections. J Appl Physiol 1989; 66 (6): 2653-8.
49. Jacoby DB, Tamaoki J, Borson DB, Nadel JA. Influenza infection causes airway hyperresponsiveness by decreasing enkephalinase. J Appl Physiol 1988; 64 (6): 2653-8.
50. Kohrogi H, Nadel JA, Malfroy B, Gorman C, Bridenbaugh R, Patton JS et al. Recombinant human enkephalinase (neutral endopeptidase) prevents cough induced by tachykinins in awake guinea pigs. J Clin Invest 1989; 84 (3): 781-6.
51. Nadel JA, Borson DB. Modulation of neurogenic inflammation by neutral endopeptidase. Am Rev Respir Dis 1991; 143: S33-6.
52. Corrao WM, Braman SS, Irwin RS. Chronic cough as the sole presenting manifestation of bronchial asthma. N Engl J Med 1979; 300 (12): 633-7.
53. Melbye H, Aasebo U, Straume B. Symptomatic effect of inhaled fenoterol in acute bronchitis: a placebocontrolled double-blind study. Fam Pract 1991; 8 (3):216-22.
54. Hueston WJ. A comparison of albuterol and erythromycin for the treatment of acute bronchitis. J Fam Pract 1991; 33 (5): 476-80.
55. Hueston WJ. Albuterol delivered by metered-dose inhaler to treat acute bronchitis. J Fam Pract 1994; 39 (5):437-40.
56. Williamson HA Jr. Pulmonary function tests in acute bronchitis: evidence for reversible airway obstruction. J Fam Pract 1987; 25 (3): 251-6.
57. Witek TJ, Doyle C, Hayden FG. The incidence of 'post viral cough' following natural colds in a community setting. Am J Respir Crit Care Med 2002; 165: 8 (2): A130.
58. Robertson AJ. Green sputum. Lancet 1952; 1: 12-15.
59. Williamson HA Jr. A randomized, controlled trial of doxycycline in the treatment of acute bronchitis. J Fam Pract 1984; 19 (4): 481-6.
60. Wright SW, Edwards KM, Decker MD, Zeldin MH. Pertussis infection in adults with persistent cough. JAMA 1995; 273 (13): 1044-6.
61. He Q, Viljanen MK, Arvilommi H, Aittanen B, Mertsola J. Whooping cough caused by Bordetella pertussis and Bordetella parapertussis in an immunized population. JAMA 1998; 280 (7): 635-7.
62. Feigin RD, Cherry JD. Pertussis. In: Bralow L, ed. Textbook of Pediatric Infectious Diseases, 3rd edn. Pennsylvania: W.B. Saunders, 1992: 1211-12.
63. Yaari E, Yafe-Zimerman Y, Schwartz SB, Slater PE, Shvartzman P, Andoren N et al. Clinical manifestations of Bordetella pertussis infection in immunized children and young adults. Chest 1999; 115 (5): 1254-8.
64. Stein RT, Sherrill D, Morgan WJ, Holberg CJ, Halonen M, Taussig LM et al. Respiratory syncytial virus in early life and risk of wheeze and allergy by age 13 years. Lancet 1999; 354: 541-5.
65. Marrie TJ. Community-acquired pneumonia. In:Niederman MS, ed. Respiratory Infections: a Scientific Basis for Management. Philadelphia: W.B. Saunders, 1994: 125-38.
66. Heckerling PS, Tape TG, Wigton RS, Hissong KK, Leikin JB, Ornato JP et al. Clinical prediction rule for pulmonary infiltrates. Ann Intern Med 1990; 113 (9):664-70.
67. Diehr P, Wood RW, Bushyhead J, Krueger L, Wolcott B, Tompkins RK. Prediction of pneumonia in outpatients with acute cough-a statistical approach. J Chronic Dis 1984; 37 (3): 215-25.
68. Singal BM, Hedges JR, Radack KL. Decision rules and clinical prediction of pneumonia: evaluation of low-yield criteria. Ann Emerg Med 1989; 18 (1): 13-20.
69. Gennis P, Gallagher J, Falvo C, Baker S, Than W. Clinical criteria for the detection of pneumonia in adults: guidelines for ordering chest roentgenograms in the emergency department. J Emerg Med 1989; 7 (3): 263-8.
70. Metlay JP, Kapoor WN, Fine MJ. Does this patient have community-acquired pneumonia? Diagnosing pneumonia by history and physical examination. JAMA 1997; 278 (17): 1440-5.
71. Metlay JP, Schulz R, Li YH, Singer DE, Marrie TJ, Coley CMet al. Influence of age on symptoms at presentation in patients with community-acquired pneumonia. Arch Intern Med 1997; 157 (13): 1453-9.
72. Monto AS, Fleming DM, Henry D, de Groot R, Makela M, Klein T et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenza A and B virus infections. J Infect Dis 1999; 180 (2): 254-61.
73. Hayden FG, Osterhaus AD, Treanor JJ, Fleming DM, Aoki FY, Nicholson KG et al. Efficacy and safety of the neuraminidase inhibitor zanamivir in the treatment of influenzavirus infections. Gg167 Influenza Study Group. N Engl J Med 1997; 337 (13): 874-80.
74. Dolin R, Reichman RC, Madore HP, Maynard R, Linton PN, Webber-Jones J. A controlled trial of amantadine and rimantadine in the prophylaxis of influenza A infection. N Engl J Med 1982; 307 (10): 580-4.
75. Melbye H, Kongerud J, Vorland L. Reversible airflow limitation in adults with respiratory infection. Eur Respir J 1994; 7 (7): 1239-45.
76. BTS Guidelines for the Management of Community Acquired Pneumonia in Adults. Thorax 2001; 56 (Suppl. 4): IV1-64.
77. Irwin RS, Boulet LP, Cloutier MM, Fuller R, Gold PM, Hoffstein V et al. Managing cough as a defense mechanism and as a symptom. A consensus panel report of the American College of Chest Physicians. Chest 1998; 114 (2 Suppl. Managing): 133S-181S.
78. Fahey T, Stocks N, Thomas T. Quantitative systematic review of randomised controlled trials comparing antibiotic with placebo for acute cough in adults. Br Med J 1998; 316: 906-10.
79. Orr PH, Scherer K, Macdonald A, Moffatt ME. Randomized placebo-controlled trials of antibiotics for acute bronchitis: a critical review of the literature. J Fam Pract 1993; 36 (5): 507-12.
80. MacKay DN. Treatment of acute bronchitis in adults without underlying lung disease. J Gen Intern Med 1996; 11 (9): 557-62.
81. Smucny JJ, Becker LA, Glazier RH, McIsaac W. Are antibiotics effective treatment for acute bronchitis? A meta-analysis. J Fam Pract 1998; 47 (6): 453-60.
82. Bent S, Saint S, Vittinghoff E, Grady D. Antibiotics in acute bronchitis: a meta-analysis. Am J Med 1999; 107 (1): 62-7.
83. Evans AT, Husain S, Durairaj L, Sadowski LS, Charles-Damte M, Wang Y. Azithromycin for acute bronchitis: a randomised, double-blind, controlled trial. Lancet 2002; 359: 1648-54.
84. Snow V, Mottur-Pilson C, Gonzales R. Principles of appropriate antibiotic use for treatment of acute bronchitis in adults. Ann Intern Med 2001; 134 (6): 518-20.
85. Gonzales R, Bartlett JG, Besser RE, Cooper RJ, Hickner JM, Hoffman JR et al. Principles of appropriate antibiotic use for treatment of uncomplicated acute bronchitis: background. Ann Intern Med 2001; 134 (6):521-9.
86. Smucny J, Flynn C, Becker L, Glazier R. Beta2-agonists for acute bronchitis. Cochrane Database Syst Rev 2001; (1): CD001726.
87. Curley FJ, Irwin RS, Pratter MR, Stivers DH, Doern GV, Vernaglia PA et al. Cough and the common cold. Am Rev Respir Dis 1988; 138 (2): 305-11.
88. Bergquist SO, Bernander S, Dahnsjo H, Sundelof B. Erythromycin in the treatment of pertussis: a study of bacteriologic and clinical effects. Pediatr Infect Dis J 1987; 6 (5): 458-61.
89. Sprauer MA, Cochi SL, Zell ER, Sutter RW, Mullen JR, Englender SJ et al. Prevention of secondary transmission of pertussis in households with early use of erythromycin. Am J Dis Child 1992; 146 (2): 177-81.
90. Wirsing von Konig CH, Postels-Multani S, Bogaerts H, Bock HL, Laukamp S, Kiederle S et al. Factors influencing the spread of pertussis in households. Eur J Pediatr 1998; 157 (5): 391-4.
91. Randomised trial of efficacy and safety of inhaled zanamivir in treatment of influenza A and B virus infections. The MIST (Management of Influenza in the Southern Hemisphere Trialists) Study Group. Lancet 1998; 352: 1877-81.
92. Jefferson T, Demicheli V, Deeks J, Rivetti D. Neuraminidase inhibitors for preventing and treating influenza in healthy adults. Cochrane Database Syst Rev 2000; (2): CD001265.
93. Rotbart HA. Treatment of picornavirus infections. Antiviral Res 2002; 53 (2): 83-98.
94. Randolph AG, Wang EE. Ribavirin for respiratory syncytial virus infection of the lower respiratory tract. Cochrane Database Syst Rev 2000; (2): CD000181.
95. American Academy of Pediatrics. Hemophilus influenza type b and respiratory syncytial virus. In: Peter G, ed.Red Book: Report of the Committee on Infectious Diseases, 24th edn. Elk Grove Village, IL: American Academy of Pediatrics, 1997: 443-7.
96. Flores G, Horwitz RI. Efficacy of beta2-agonists in bronchiolitis: a reappraisal and meta-analysis. Pediatrics 1997; 100: 233-9.
97. Garrison MM, Christakis DA, Harvey E, Cummings P, Davis RL. Systemic corticosteroids in infant bronchiolitis:a meta-analysis. Pediatrics 2000; 105 (4): E44.
98. Cade A, Brownlee KG, Conway SP, Haigh D, Short A, Brown J et al. Randomised placebo controlled trial of nebulised corticosteroids in acute respiratory syncytial viral bronchiolitis. Arch Dis Child 2000; 82 (2): 126-30.
99. Bulow SM, Nir M, Levin E, Friis B, Thomsen LL, Nielsen JE et al. Prednisolone treatment of respiratory syncytial virus infection: a randomized controlled trial of 147 infants. Pediatrics 1999; 104 (6): e77.
100. Ledwith CA, Shea LM, Mauro RD. Safety and efficacy of nebulized racemic epinephrine in conjunction with oral dexamethasone and mist in the outpatient treatment of croup. Ann Emerg Med 1995; 25 (3): 331-7.
101. Waisman Y, Klein BL, Boenning DA, Young GM, Chamberlain JM, O'Donnell R et al. Prospective randomized double-blind study comparing 1-epinephrine and racemic epinephrine aerosols in the treatment of laryngotracheitis (croup). Pediatrics 1992; 89 (2):302-6.
102. Fitzgerald D, Mellis C, Johnson M, Allen H, Cooper P, Van Asperen P. Nebulized budesonide is as effective as nebulized adrenaline in moderately severe croup. Pediatrics 1996; 97 (5): 722-5.
103. Wright RB, Pomerantz WJ, Luria JW. New approaches to respiratory infections in children. Bronchiolitis and croup. Emerg Med Clin North Am 2002; 20 (1): 93-114.
104. Super DM, Cartelli NA, Brooks LJ, Lembo RM, Kumar ML. A prospective randomized double-blind study to evaluate the effect of dexamethasone in acute laryngotracheitis. J Pediatr 1989; 115 (2): 323-9.
105. Geelhoed GC, Macdonald WB. Oral dexamethasone in the treatment of croup: 0.15 mg/kg versus 0.3mg/kg versus 0.6 mg/kg. Pediatr Pulmonol 1995; 20 (6): 362-8.
106. Klassen TP, Feldman ME, Watters LK, Sutcliffe T, Rowe PC. Nebulized budesonide for children with mild-tomoderate croup. N Engl J Med 1994; 331 (5): 285-9.
107. Johnson DW, Jacobson S, Edney PC, Hadfield P, Mundy ME, Schuh S. A comparison of nebulized budesonide, intramuscular dexamethasone, and placebo for moderately severe croup. N Engl J Med 1998; 339 (8):498-503.
108. Klassen TP, Craig WR, Moher D, Osmond MH, Pasterkamp H, Sutcliffe T et al. Nebulized budesonide and oral dexamethasone for treatment of croup: a randomized controlled trial. JAMA 1998; 279 (20):1629-32.
109. Ausejo M, Saenz A, Pham B, Kellner JD, Johnson DW, Moher D et al. Glucocorticoids for croup. Cochrane Database Syst Rev 2000; (2): CD001955.
110. Geelhoed GC, Turner J, Macdonald WB. Efficacy of a small single dose of oral dexamethasone for outpatient croup: a double blind placebo controlled clinical trial. Br Med J 1996; 313: 140-2.
111. Heffelfinger JD, Dowell SF, Jorgensen JH, Klugman KP, Mabry LR, Musher DM et al. Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med 2000; 160 (10): 1399-408.
112. Irwin RS, Curley FJ. The treatment of cough. A comprehensive review. Chest 1991; 99 (6): 1477-84.
113. Schroeder K, Fahey T. Systematic review of randomised controlled trials of over the counter cough medicines for acute cough in adults. Br Med J 2002; 324: 329-31.